Literature DB >> 33670088

Mesonephric-Like Adenocarcinoma of the Endometrium: Diagnostic Advances to Spot This Wolf in Sheep's Clothing. A Review of the Literature.

Ellen Deolet1, Jo Van Dorpe1,2, Koen Van de Vijver1,2.   

Abstract

Mesonephric-like adenocarcinoma is a recently described rare neoplasm occurring in the uterine corpus and ovary. This under-recognized subtype of carcinoma can be very challenging to diagnose. In mesonephric adenocarcinoma a variety of growth patterns can be present within the same tumor, as a result of which they can be misinterpreted and diagnosed as low-grade endometrioid adenocarcinoma, clear cell carcinoma, or even serous carcinoma and carcinosarcoma. We report a case of mesonephric-like adenocarcinoma misdiagnosed as a low-grade endometrioid endometrial adenocarcinoma that had an early local recurrence and metastasized to the liver and the lungs. Histopathological, immunohistochemical and molecular analysis were performed and compared to published literature, providing a comprehensive overview of the current knowledge. Databases (Pubmed, Web of Science, Google Scholar) were searched with a combination of the following search terms: mesonephric-like, mesonephric, adenocarcinoma, carcinoma, uterine body, uterine corpus, endometrium. Mesonephric-like adenocarcinoma is a difficult-to-diagnose entity. Advanced diagnostics, including improved morphologic, immunohistochemical and molecular knowledge can help develop new therapeutic strategies against this specific subtype of endometrial cancer with an aggressive clinical behavior.

Entities:  

Keywords:  KRAS; endometrium; histology; immunohistochemistry; mesonephric-like adenocarcinoma; molecular; uterus

Year:  2021        PMID: 33670088     DOI: 10.3390/jcm10040698

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

Review 1.  Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.

Authors:  Han Gyeol Kim; Hyunjin Kim; Min-Kyung Yeo; Kyu Yeoun Won; Young Sun Kim; Gwan Hee Han; Hyun-Soo Kim; Kiyong Na
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

2.  Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.

Authors:  Tianshi Ma; Mengyu Chai; Huafeng Shou; Guoqing Ru; Ming Zhao
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

3.  Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma.

Authors:  Sherry Shen; Maria M Rubinstein; Kay J Park; Jason A Konner; Vicky Makker
Journal:  Gynecol Oncol Rep       Date:  2021-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.